Abstract
Background
Prior work has shown that the competitiveness of the market in which hospitals operate is associated with use of surgical procedures. This study examined the association between regional market competition and use of breast reconstruction for women with breast cancer and ductal carcinoma in situ undergoing mastectomy.
Methods
Women who underwent mastectomy from 2010 to 2011 recorded in the National Inpatient Sample were selected. The competitive market environment for each hospital in which patients were treated was estimated using the Herfindahl–Hirschman Index. Multivariable models were developed to examine the association between regional market competition and breast reconstruction, with adjustment for other clinical, demographic, and structural variables.
Results
Immediate breast reconstruction was performed for 9902 (45%) of 22,011 women. The rate of immediate breast reconstruction was 34.5% at hospitals in non-competitive markets, 49% at hospitals in moderately competitive markets, and 56.4% at hospitals in highly competitive markets (P < 0.0001). In a multivariable model, women in moderately competitive markets were 24% (risk ratio [RR] 1.24; 95% confidence interval [CI] 1.10–1.41) more likely to undergo immediate breast reconstruction than women in noncompetitive markets, whereas those in competitive markets were 25% (RR 1.25; 95% CI 1.11–1.41) more likely to have reconstruction. Later year of treatment, higher census tract income level, and residence in an urban area were associated with an increased likelihood of reconstruction (P < 0.05 for all). In contrast, older age, non-white race, and non-commercial insurance were associated with a lower likelihood of reconstruction (P < 0.05 for all).
Conclusion
Patients who undergo mastectomy at hospitals in competitive markets are more likely to undergo immediate breast reconstruction.
Similar content being viewed by others
References
Wilkins EG, Cederna PS, Lowery JC, et al. Prospective analysis of psychosocial outcomes in breast reconstruction: one-year postoperative results from the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg. 2000;106:1014–25; discussion 1026–1027.
Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg. 2008;247:1019–28.
Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92:1422–9.
Al-Ghazal SK, Sully L, Fallowfield L, Blamey RW. The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol. 2000;26:17–9.
Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626–34.
Ilonzo N, Tsang A, Tsantes S, Estabrook A, Thu Ma AM. Breast reconstruction after mastectomy: a ten-year analysis of trends and immediate postoperative outcomes. Breast. 2017;32:7–12.
Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919–26.
8. Hershman DL, Richards CA, Kalinsky K, et al. Influence of health insurance, hospital factors, and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Res Treat. 2012;136:535–45.
Wright JD, Tergas AI, Hou JY, et al. Effect of regional hospital competition and hospital financial status on the use of robotic-assisted surgery. JAMA Surg. 2016 151:612–620.
Dor A, Koroukian S, Xu F, Stulberg J, Delaney C, Cooper G. Pricing of surgeries for colon cancer: patient severity and market factors. Cancer. 2012;118:5741–8.
Sethi RK, Henry AJ, Hevelone ND, Lipsitz SR, Belkin M, Nguyen LL. Impact of hospital market competition on endovascular aneurysm repair adoption and outcomes. J Vasc Surg. 2013;58:596–606.
Richards CA, Rundle AG, Wright JD, Hershman DL. Association between hospital financial distress and immediate breast reconstruction surgery after mastectomy among women with ductal carcinoma in situ. JAMA Surg. 2017 153:344–351.
Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP), 2007–2009. Agency for Healthcare Research and Quality, Rockville, MD. Retrieved 26 January 2014 at http://www.hcup-us.ahrq.gov/nisoverview.jsp.
HCUP Hospital Market Structure Files. Retrieved 5 January 2015 at http://www.hcup-us.ahrq.gov/toolssoftware/hms/hms.jsp.
Wong HS, Zhan, C., Mutter, R. Do different measures of hospital competion matter in empirical investigations of hospital behavior? Rev Industr Organ. 2005;26:61–87.
Federal Trade Commission; Department of Justice. Horizonal Merger Guidelines. 8 April 2015 at http://www.justice.gov/atr/public/guidelines/hmg-2010.html.
Baker LC, Bundorf MK, Royalty AB, Levin Z. Physician practice competition and prices paid by private insurers for office visits. JAMA. 2014;312:1653–62.
Cutler DM, Scott Morton F. Hospitals, market share, and consolidation. JAMA. 2013;310:1964–70.
Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study. Lancet Oncol. 2017;18:1445–53.
Cerullo M, Chen SY, Dillhoff M, Schmidt C, Canner JK, Pawlik TM. Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery. JAMA Surg. 2017;152:e172158.
Haley DR, Zhao M, Spaulding A, Hamadi H, Xu J, Yeomans K. The influence of hospital market competition on patient mortality and total performance score. Health Care Manage Frederick. 2016;35:266–76.
Glick DB, Wroblewski K, Apfelbaum S, Dauber B, Woo J, Tung A. The relationship between competition and quality in procedural cardiac care. Anesth Analg. 2015;120:220–9.
Maeda JL, LoSasso AT. Effect of market competition on hospital performance for heart failure. Am J Manage Care. 2011;17:816–22.
Chang DC, Shiozawa A, Nguyen LL, et al. Cost of inpatient care and its association with hospital competition. J Am Coll Surg. 2011;212:12–9.
Robinson JC, Luft HS. The impact of hospital market structure on patient volume, average length of stay, and the cost of care. J Health Econ. 1985;4:333–56.
Robinson JC, Luft HS. Competition and the cost of hospital care, 1972 to 1982. JAMA. 1987;257:3241–5.
Yang RL, Newman AS, Lin IC, et al. Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation. Cancer. 2013;119:2462–8.
Kruper L, Xu X, Henderson K, Bernstein L. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer. Ann Surg Oncol. 2011;18:3210–9.
Alderman AK, McMahon L Jr, Wilkins EG. The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg. 2003;111:695–703; discussion 704–705.
Xie Y, Tang Y, Wehby GL. Federal health coverage mandates and health care utilization: the case of the Women’s Health and Cancer Rights Act and use of breast reconstruction surgery. J Womens Health Larchmt. 2015;24:655–62.
Fu R, Baser, O, Kurlansky, P, Means, J, Rohde, C. Abstract 31: The Impact of the 2010 NY State Breast Cancer Provider Discussion Law on Breast Reconstruction Rates: An Analysis of 42,137 Patients From the NY SPARCS Database. Plast Reconstr Surg Glob Open. 2017;5(4 Suppl):25.
Bauder AR, Gross CP, Killelea BK, Butler PD, Kovach SJ, Fox JP. The relationship between geographic access to plastic surgeons and breast reconstruction rates among women undergoing mastectomy for cancer. Ann Plast Surg. 2017;78:324–9.
Butler PD, Familusi O, Serletti JM, Fox JP. Influence of race, insurance status, and geographic access to plastic surgeons on immediate breast reconstruction rates. Am J Surg. 2017 215:987–994.
Bauder AR, Sarik JR, Butler PD, et al. Geographic variation in access to plastic surgeons. Ann Plast Surg. 2016;76:238–43.
Acknowledgment
Dr. Jason D. Wright (NCI R01CA169121-01A1) is a recipient of a grant from the National Cancer Institute. Dr. Dawn L. Hershman is the recipient of grants from the Breast Cancer Research Foundation, the Conquer Cancer Foundation, and the Susan Komen Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Dr. Jason D. Wright has served as a consultant for Tesaro and Clovis Oncology. Dr. Neugut has served as a consultant to Pfizer, Teva, Eisai, Otsuka, and United Biosource Corporation. He is on the medical advisory board of EHE, International. No other authors have any conflicts of interest or disclosures.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wright, J.D., Chen, L., Accordino, M. et al. Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy. Ann Surg Oncol 26, 62–70 (2019). https://doi.org/10.1245/s10434-018-6825-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6825-7